Flare Therapeutics

Flare fires up with $123M series B to target transcription factors with 3 Big Pharmas in tow
Fierce Biotech
Wed, 03/22/23 - 10:13 am
Flare Therapeutics
funding
Pfizer
Eli Lilly
Novartis
transcription factors
Third Rock launches biotech targeting 'notoriously difficult' DNA regulators
BioPharma Dive
Thu, 05/13/21 - 10:59 am
DNA
Third Rock
biotech
transcription factors
Flare Therapeutics